Consistently, reconstitution of Gata3 in Gata3- or Brca1-deficient human and mouse mammary tumor cells restores the expression of c-Fos and suppresses Fra1 in inhibiting EMT, motility, invasion, and tumorigenesis. This evidence concerns the gene FOS and breast cancer.